Global Intravenous Immunoglobulin (IVIg) Market Insights and Forecast to 2027

Global Intravenous Immunoglobulin (IVIg) Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Intravenous Immunoglobulin (IVIg) Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type
1.4.2 IVIg Liquid
1.4.3 IVIg Powder
1.3 Market by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts 2016-2027
2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Estimates and Forecasts 2016-2027
2.3 Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Intravenous Immunoglobulin (IVIg) Regions by Sales
2.4.1 Global Top Intravenous Immunoglobulin (IVIg) Regions by Sales (2016-2021)
2.4.2 Global Top Intravenous Immunoglobulin (IVIg) Regions by Sales (2022-2027)
2.5 Global Top Intravenous Immunoglobulin (IVIg) Regions by Revenue
2.5.1 Global Top Intravenous Immunoglobulin (IVIg) Regions by Revenue (2016-2021)
2.5.2 Global Top Intravenous Immunoglobulin (IVIg) Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers
3.1.1 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Sales (2016-2021)
3.1.2 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Intravenous Immunoglobulin (IVIg) Sales in 2020
3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers
3.2.1 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Intravenous Immunoglobulin (IVIg) Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Intravenous Immunoglobulin (IVIg) Revenue in 2020
3.3 Global Intravenous Immunoglobulin (IVIg) Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Intravenous Immunoglobulin (IVIg) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type
4.1.1 Global Intravenous Immunoglobulin (IVIg) Historical Sales by Type (2016-2021)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Sales by Type (2022-2027)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2016-2027)
4.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type
4.2.1 Global Intravenous Immunoglobulin (IVIg) Historical Revenue by Type (2016-2021)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Revenue by Type (2022-2027)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2016-2027)
4.3 Global Intravenous Immunoglobulin (IVIg) Price by Type
4.3.1 Global Intravenous Immunoglobulin (IVIg) Price by Type (2016-2021)
4.3.2 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application
5.1.1 Global Intravenous Immunoglobulin (IVIg) Historical Sales by Application (2016-2021)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Sales by Application (2022-2027)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2016-2027)
5.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application
5.2.1 Global Intravenous Immunoglobulin (IVIg) Historical Revenue by Application (2016-2021)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Revenue by Application (2022-2027)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2016-2027)
5.3 Global Intravenous Immunoglobulin (IVIg) Price by Application
5.3.1 Global Intravenous Immunoglobulin (IVIg) Price by Application (2016-2021)
5.3.2 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2022-2027)
6 North America
6.1 North America Intravenous Immunoglobulin (IVIg) Market Size by Type
6.1.1 North America Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2027)
6.1.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2027)
6.2 North America Intravenous Immunoglobulin (IVIg) Market Size by Application
6.2.1 North America Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2027)
6.2.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2027)
6.3 North America Intravenous Immunoglobulin (IVIg) Market Size by Country
6.3.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2027)
6.3.2 North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Intravenous Immunoglobulin (IVIg) Market Size by Type
7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2017-2027)
7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2017-2027)
7.2 Europe Intravenous Immunoglobulin (IVIg) Market Size by Application
7.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2017-2027)
7.2.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2017-2027)
7.3 Europe Intravenous Immunoglobulin (IVIg) Market Size by Country
7.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2017-2027)
7.3.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Type
8.1.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2018-2027)
8.1.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Type (2018-2027)
8.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Application
8.2.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2018-2027)
8.2.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Application (2018-2027)
8.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Size by Region
8.3.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2018-2027)
8.3.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Type
9.1.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2019-2027)
9.1.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Type (2019-2027)
9.2 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Application
9.2.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2019-2027)
9.2.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Application (2019-2027)
9.3 Latin America Intravenous Immunoglobulin (IVIg) Market Size by Country
9.3.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2019-2027)
9.3.2 Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Type
6.1.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2027)
6.1.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2027)
6.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Application
6.2.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2027)
6.2.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2027)
6.3 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Size by Country
6.3.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2027)
6.3.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Overview
11.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Description
11.1.5 Baxter Related Developments
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Overview
11.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Grifols Intravenous Immunoglobulin (IVIg) Product Description
11.2.5 Grifols Related Developments
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Overview
11.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 CSL Intravenous Immunoglobulin (IVIg) Product Description
11.3.5 CSL Related Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Product Description
11.4.5 Octapharma Related Developments
11.5 Biotest
11.5.1 Biotest Corporation Information
11.5.2 Biotest Overview
11.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Biotest Intravenous Immunoglobulin (IVIg) Product Description
11.5.5 Biotest Related Developments
11.6 Kedrion
11.6.1 Kedrion Corporation Information
11.6.2 Kedrion Overview
11.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Product Description
11.6.5 Kedrion Related Developments
11.7 Hualan Bio
11.7.1 Hualan Bio Corporation Information
11.7.2 Hualan Bio Overview
11.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Description
11.7.5 Hualan Bio Related Developments
11.8 CNBG
11.8.1 CNBG Corporation Information
11.8.2 CNBG Overview
11.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 CNBG Intravenous Immunoglobulin (IVIg) Product Description
11.8.5 CNBG Related Developments
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Corporation Information
11.9.2 Shanghai RAAS Overview
11.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Description
11.9.5 Shanghai RAAS Related Developments
11.10 CBPO
11.10.1 CBPO Corporation Information
11.10.2 CBPO Overview
11.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 CBPO Intravenous Immunoglobulin (IVIg) Product Description
11.10.5 CBPO Related Developments
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Overview
11.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Baxter Intravenous Immunoglobulin (IVIg) Product Description
11.1.5 Baxter Related Developments
11.12 BPL
11.12.1 BPL Corporation Information
11.12.2 BPL Overview
11.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 BPL Product Description
11.12.5 BPL Related Developments
11.13 Sichuan Yuanda Shuyang
11.13.1 Sichuan Yuanda Shuyang Corporation Information
11.13.2 Sichuan Yuanda Shuyang Overview
11.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Sichuan Yuanda Shuyang Product Description
11.13.5 Sichuan Yuanda Shuyang Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Intravenous Immunoglobulin (IVIg) Value Chain Analysis
12.2 Intravenous Immunoglobulin (IVIg) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intravenous Immunoglobulin (IVIg) Production Mode & Process
12.4 Intravenous Immunoglobulin (IVIg) Sales and Marketing
12.4.1 Intravenous Immunoglobulin (IVIg) Sales Channels
12.4.2 Intravenous Immunoglobulin (IVIg) Distributors
12.5 Intravenous Immunoglobulin (IVIg) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Intravenous Immunoglobulin (IVIg) Industry Trends
13.2 Intravenous Immunoglobulin (IVIg) Market Drivers
13.3 Intravenous Immunoglobulin (IVIg) Market Challenges
13.4 Intravenous Immunoglobulin (IVIg) Market Restraints
14 Key Findings in The Global Intravenous Immunoglobulin (IVIg) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of IVIg Liquid
Table 3. Major Manufacturers of IVIg Powder
Table 4. Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Intravenous Immunoglobulin (IVIg) Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) & (K Bottle)
Table 7. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Table 8. Global Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) & (K Bottle)
Table 9. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2022-2027)
Table 10. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2016-2021)
Table 12. Global Intravenous Immunoglobulin (IVIg) Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2022-2027)
Table 14. Global Intravenous Immunoglobulin (IVIg) Sales by Manufacturers (2016-2021) & (K Bottle)
Table 15. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers (2016-2021)
Table 16. Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2016-2021)
Table 18. Intravenous Immunoglobulin (IVIg) Price by Manufacturers 2016-2021 (USD/Bottle)
Table 19. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2020)
Table 21. Intravenous Immunoglobulin (IVIg) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Intravenous Immunoglobulin (IVIg) Product Offered
Table 23. Date of Manufacturers Enter into Intravenous Immunoglobulin (IVIg) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 26. Global Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 27. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2016-2021)
Table 28. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2022-2027)
Table 29. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2016-2021)
Table 32. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2022-2027)
Table 33. Intravenous Immunoglobulin (IVIg) Price by Type (2016-2021) & (USD/Bottle)
Table 34. Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2022-2027) & (USD/Bottle)
Table 35. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 36. Global Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 37. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2016-2021)
Table 38. Global Intravenous Immunoglobulin (IVIg) Sales Share by Application (2022-2027)
Table 39. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2016-2021)
Table 42. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Application (2022-2027)
Table 43. Intravenous Immunoglobulin (IVIg) Price by Application (2016-2021) & (USD/Bottle)
Table 44. Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2022-2027) & (USD/Bottle)
Table 45. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 46. North America Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 47. North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Intravenous Immunoglobulin (IVIg) Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 50. North America Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 51. North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Intravenous Immunoglobulin (IVIg) Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 54. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2022-2027) & (K Bottle)
Table 55. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 58. Europe Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 59. Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Intravenous Immunoglobulin (IVIg) Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 62. Europe Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 63. Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Intravenous Immunoglobulin (IVIg) Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 66. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2022-2027) & (K Bottle)
Table 67. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 70. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 71. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 74. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 75. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2016-2021) & (K Bottle)
Table 78. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2022-2027) & (K Bottle)
Table 79. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 82. Latin America Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 83. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 86. Latin America Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 87. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 90. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2022-2027) & (K Bottle)
Table 91. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2016-2021) & (K Bottle)
Table 94. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Type (2022-2027) & (K Bottle)
Table 95. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2016-2021) & (K Bottle)
Table 98. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Application (2022-2027) & (K Bottle)
Table 99. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2016-2021) & (K Bottle)
Table 102. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2022-2027) & (K Bottle)
Table 103. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2022-2027) & (US$ Million)
Table 105. Baxter Corporation Information
Table 106. Baxter Description and Major Businesses
Table 107. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 108. Baxter Intravenous Immunoglobulin (IVIg) Product
Table 109. Baxter Recent Developments
Table 110. Grifols Corporation Information
Table 111. Grifols Description and Major Businesses
Table 112. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 113. Grifols Intravenous Immunoglobulin (IVIg) Product
Table 114. Grifols Recent Developments
Table 115. CSL Corporation Information
Table 116. CSL Description and Major Businesses
Table 117. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 118. CSL Intravenous Immunoglobulin (IVIg) Product
Table 119. CSL Recent Developments
Table 120. Octapharma Corporation Information
Table 121. Octapharma Description and Major Businesses
Table 122. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 123. Octapharma Intravenous Immunoglobulin (IVIg) Product
Table 124. Octapharma Recent Developments
Table 125. Biotest Corporation Information
Table 126. Biotest Description and Major Businesses
Table 127. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 128. Biotest Intravenous Immunoglobulin (IVIg) Product
Table 129. Biotest Recent Developments
Table 130. Kedrion Corporation Information
Table 131. Kedrion Description and Major Businesses
Table 132. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 133. Kedrion Intravenous Immunoglobulin (IVIg) Product
Table 134. Kedrion Recent Developments
Table 135. Hualan Bio Corporation Information
Table 136. Hualan Bio Description and Major Businesses
Table 137. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 138. Hualan Bio Intravenous Immunoglobulin (IVIg) Product
Table 139. Hualan Bio Recent Developments
Table 140. CNBG Corporation Information
Table 141. CNBG Description and Major Businesses
Table 142. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 143. CNBG Intravenous Immunoglobulin (IVIg) Product
Table 144. CNBG Recent Developments
Table 145. Shanghai RAAS Corporation Information
Table 146. Shanghai RAAS Description and Major Businesses
Table 147. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 148. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product
Table 149. Shanghai RAAS Recent Developments
Table 150. CBPO Corporation Information
Table 151. CBPO Description and Major Businesses
Table 152. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 153. CBPO Intravenous Immunoglobulin (IVIg) Product
Table 154. CBPO Recent Developments
Table 155. LFB Group Corporation Information
Table 156. LFB Group Description and Major Businesses
Table 157. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 158. LFB Group Intravenous Immunoglobulin (IVIg) Product
Table 159. LFB Group Recent Developments
Table 160. BPL Corporation Information
Table 161. BPL Description and Major Businesses
Table 162. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 163. BPL Intravenous Immunoglobulin (IVIg) Product
Table 164. BPL Recent Developments
Table 165. Sichuan Yuanda Shuyang Corporation Information
Table 166. Sichuan Yuanda Shuyang Description and Major Businesses
Table 167. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2016-2021)
Table 168. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product
Table 169. Sichuan Yuanda Shuyang Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Intravenous Immunoglobulin (IVIg) Distributors List
Table 173. Intravenous Immunoglobulin (IVIg) Customers List
Table 174. Intravenous Immunoglobulin (IVIg) Market Trends
Table 175. Intravenous Immunoglobulin (IVIg) Market Drivers
Table 176. Intravenous Immunoglobulin (IVIg) Market Challenges
Table 177. Intravenous Immunoglobulin (IVIg) Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Immunoglobulin (IVIg) Product Picture
Figure 2. Global Intravenous Immunoglobulin (IVIg) Market Share by Type in 2020 & 2027
Figure 3. IVIg Liquid Product Picture
Figure 4. IVIg Powder Product Picture
Figure 5. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2020 & 2027
Figure 6. Immunodeficiency
Figure 7. Autoimmune Disease
Figure 8. Acute Infection
Figure 9. Intravenous Immunoglobulin (IVIg) Report Years Considered
Figure 10. Global Intravenous Immunoglobulin (IVIg) Sales 2016-2027 (K Bottle)
Figure 11. Global Intravenous Immunoglobulin (IVIg) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Intravenous Immunoglobulin (IVIg) Revenue 2016-2027 (US$ Million)
Figure 13. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2016-2021)
Figure 15. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2022-2027)
Figure 16. North America Intravenous Immunoglobulin (IVIg) Sales YoY (2016-2027) & (K Bottle)
Figure 17. North America Intravenous Immunoglobulin (IVIg) Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Intravenous Immunoglobulin (IVIg) Sales YoY (2016-2027) & (K Bottle)
Figure 19. Europe Intravenous Immunoglobulin (IVIg) Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales YoY (2016-2027) & (K Bottle)
Figure 21. Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue YoY (2016-2027) & (US$ Million)
Figure 22

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs